Agency Archives - Page 16 of 21

What the HHS Reorganization Means for BARDA, Contractors, and the Office of Healthy Futures

Leave a Comment / All Posts, BARDA, Life Sciences / By Eric Jia-Sobota, Founder

The U.S. Department of Health and Human Services (HHS) is undergoing one of the most significant structural transformations in its history. This realignment affects not only public health preparedness and biomedical innovation but also the broader operational framework, including funding mechanisms, programmatic leadership, and cross-agency coordination structures that supports millions of Americans across health care,

What the HHS Reorganization Means for BARDA, Contractors, and the Office of Healthy Futures Read More »

DARPA ERIS digital marketplace disruptive solutions

DARPA’s ERIS Marketplace

Leave a Comment / All Posts, DARPA, Emerging Technologies / By Max Higgins, Senior Consultant

DARPA_PS_25-05_R3_ERIS_Announcement_1_Feb_2025_ (3) Overview The Defense Advanced Research Projects Agency (DARPA) is the U.S. Department of Defense’s premier agency for driving technological innovation and funding breakthrough capabilities to ensure national security. Known for pioneering technologies like the internet and GPS, DARPA focuses on high-risk, high-reward research that can lead to the development of critical strategic products.

DARPA’s ERIS Marketplace Read More »

ARPA-H Mission Office Innovative Solutions Openings (ISOs)

Leave a Comment / All Posts, ARPA-H, Life Sciences / By Max Higgins, Senior Consultant

Overview The Advanced Research Projects Agency for Health (ARPA-H) is dedicated to accelerating transformative health solutions by tackling some of the most pressing challenges in biomedical and healthcare innovation. As part of this mission, ARPA-H has launched Mission Office Innovative Solutions Openings (ISOs) that promote the development of health technologies that lie outside of the

ARPA-H Mission Office Innovative Solutions Openings (ISOs) Read More »

Expedited Research Implementation Series (ERIS)

Leave a Comment / All Posts, DARPA, Emerging Technologies / By Max Higgins, Senior Consultant

What is the ERIS? The Expedited Research Implementation Series (ERIS) is a cutting-edge initiative launched by the Defense Advanced Research Projects Agency (DARPA) in partnership with the Applied Research Institute (ARI). ERIS serves as a digital marketplace that facilitates the submission, assessment, and acquisition of breakthrough technologies through rapid acquisition pathways. This unique initiative enables

Expedited Research Implementation Series (ERIS) Read More »

RAPID Solicitation

Leave a Comment / All Posts, ARPA-H, Life Sciences / By Max Higgins, Senior Consultant

RAPID_SOL_25_119_FINAL Overview The Advanced Research Projects Agency for Health (ARPA-H) recently announced the newly approved program for Rare disease AI/ML for Precision Integrated Diagnostics (RAPID). The RAPID program aims to significantly improve outcomes for people with rare diseases by reducing diagnostic delays by ≥50%, decreasing misdiagnosis rates, and expanding access to diagnostics. Beyond benefitting the treatment experience of

RAPID Solicitation Read More »

Safe Lithium-Ion Battery Development

Leave a Comment / All Posts, DOE, Emerging Technologies / By Max Higgins, Senior Consultant

Lithium Ion Battery Development Overview of the Solicitation The Department of Energy (DOE) and affiliates have released a Request for Proposals (RFP) for the development of a safe lithium-ion battery. This initiative aims to create a backup energy storage system capable of providing 2.4 MW*hrs of usable energy while ensuring a robust safety posture. The

Safe Lithium-Ion Battery Development Read More »

Unlocking the Future of Microsystems: DARPA’s MICA Program

Leave a Comment / All Posts, DARPA, Emerging Technologies / By Max Higgins, Senior Consultant

DARPA, Microsystems Induced CAtalysis (MICA) Program Overview of the MICA Program The Defense Advanced Research Projects Agency (DARPA) has recently announced a groundbreaking funding opportunity, titled “Microsystems Induced CAtalysis” (MICA). This Broad Agency Announcement (BAA) aims to enhance molecular science by creating advanced tools and techniques for controlling molecular catalysts using microsystems. This initiative goes

Unlocking the Future of Microsystems: DARPA’s MICA Program Read More »

antiviral therapeutics against filoviruses

New Opportunities with DRIVe: ReBooT and RePAIR Amendments

Leave a Comment / All Posts, BARDA, Life Sciences / By Max Higgins, Senior Consultant

Amendment 034 – DRIVe EZ BAA_ReBooT_RePAIR New Opportunities with DRIVe: ReBooT and RePAIR Amendments The Biomedical Advanced Research and Development Authority’s (BARDA) Division of Research, Innovation & Ventures (DRIVe) has announced updates to its Easy Broad Agency Announcement (EZ-BAA) with Amendment #034. This amendment reopens and revises the ReBooT (AOI #22) program and pauses the

New Opportunities with DRIVe: ReBooT and RePAIR Amendments Read More »

Leveraging AI to Enhance Business Intelligence

Leave a Comment / All Posts, DIU, Emerging Technologies / By Max Higgins, Senior Consultant

DOD’s New Initiative_AOI Solicitation Leveraging AI to Enhance Business Intelligence: The DoD’s New Initiative The Department of Defense (DoD) has identified a critical need to modernize business intelligence assessments to keep pace with evolving challenges in due diligence evaluations and industrial foreign influence analyses. To address this, the Defense Innovation Unit (DIU) has released an

Leveraging AI to Enhance Business Intelligence Read More »

ARPA-H_EIH health and biomedical research

Emerging Health Innovators (EHI) Initiative

Leave a Comment / All Posts, ARPA-H, Life Sciences / By Max Higgins, Senior Consultant

ARPA_H_SOL_25_118_EHI_Solicitation (1) Emerging Health Innovators Solicitation: An Opportunity to Revolutionize Health Innovation The Advanced Research Projects Agency for Health (ARPA-H) has issued the Emerging Health Innovators (EHI) Initiative Solicitation (ARPA-H-SOL-25-118), a groundbreaking funding opportunity aimed at empowering both early-career researchers and community innovators to advance health and biomedical research. Through the EHI Initiative, ARPA-H seeks

Emerging Health Innovators (EHI) Initiative Read More »

EverGlade Funding Alert: Proposer’s Day for Rare disease AI/ML for Precision Integrated Diagnostics (RAPID)

Leave a Comment / All Posts, ARPA-H, Life Sciences / By Max Higgins, Senior Consultant

RAPID_Special_Notice ARPA-H’s RAPID Program The Advanced Research Projects Agency for Health (ARPA-H) recently announced the newly approved program for Rare disease AI/ML for Precision Integrated Diagnostics (RAPID). This initiative aims to revolutionize the prolonged diagnostic odyssey faced by millions of rare disease patients worldwide. Utilizing fragmented datasets and state-of-the-art technologies, RAPID aims to democratize access

EverGlade Funding Alert: Proposer’s Day for Rare disease AI/ML for Precision Integrated Diagnostics (RAPID) Read More »

EverGlade Funding Alert: PROactive Solutions for Prolonging Resilience (PROSPR)

Leave a Comment / All Posts, ARPA-H, Life Sciences / By Max Higgins, Senior Consultant

ARPA-H-SOL-25-125_Special_Notice ARPA-H’s PROSPR Program The Advanced Research Projects Agency for Health (ARPA-H) has announced the PROactive Solutions for Prolonging Resilience (PROSPR) initiative, an ambitious program designed to extend the healthspan of Americans by addressing the underlying causes of age-related health loss. By pioneering innovative interventions that target age-induced health deterioration, ARPA-H aims to revolutionize healthcare

EverGlade Funding Alert: PROactive Solutions for Prolonging Resilience (PROSPR) Read More »